» Articles » PMID: 38575340

Adenine-induced Animal Model of Chronic Kidney Disease: Current Applications and Future Perspectives

Overview
Journal Ren Fail
Publisher Informa Healthcare
Date 2024 Apr 4
PMID 38575340
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD) with high morbidity and mortality all over the world is characterized by decreased kidney function, a condition which can result from numerous risk factors, including diabetes, hypertension and obesity. Despite significant advances in our understanding of the pathogenesis of CKD, there are still no treatments that can effectively combat CKD, which underscores the urgent need for further study into the pathological mechanisms underlying this condition. In this regard, animal models of CKD are indispensable. This article reviews a widely used animal model of CKD, which is induced by adenine. While a physiologic dose of adenine is beneficial in terms of biological activity, a high dose of adenine is known to induce renal disease in the organism. Following a brief description of the procedure for disease induction by adenine, major mechanisms of adenine-induced CKD are then reviewed, including inflammation, oxidative stress, programmed cell death, metabolic disorders, and fibrillation. Finally, the application and future perspective of this adenine-induced CKD model as a platform for testing the efficacy of a variety of therapeutic approaches is also discussed. Given the simplicity and reproducibility of this animal model, it remains a valuable tool for studying the pathological mechanisms of CKD and identifying therapeutic targets to fight CKD.

Citing Articles

Effect of Riociguat on Adenine-Induced Chronic Kidney Disease in Rats.

Abdelrahman A, Al Maskari R, Ali H, Manoj P, Al Suleimani Y Biology (Basel). 2025; 14(2).

PMID: 40001929 PMC: 11851967. DOI: 10.3390/biology14020161.


Aquaporin-2 in the early stages of the adenine-induced chronic kidney disease model.

Oronel L, Ortiz M, Yarza C, Gayone S, Davio C, Majowicz M PLoS One. 2025; 20(1):e0314827.

PMID: 39883648 PMC: 11781631. DOI: 10.1371/journal.pone.0314827.


Pseudogenization of the Slc23a4 gene is necessary for the survival of Xdh-deficient mice.

Terada K, Watanabe T, Yasuno N, Ohtsubo T, Shibata S, Ichida K Sci Rep. 2025; 15(1):3250.

PMID: 39863758 PMC: 11762782. DOI: 10.1038/s41598-025-87751-9.


Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomes.

Beikoghli Kalkhoran S, Basalay M, He Z, Golforoush P, Roper T, Caplin B Basic Res Cardiol. 2024; 119(6):937-955.

PMID: 39472324 PMC: 11628583. DOI: 10.1007/s00395-024-01086-6.


Nephroprotective effect of pioglitazone in a Wistar rat model of adenine‑induced chronic kidney disease.

Perez-Villalobos M, Barba-Gonzalez A, Garcia-Carrillo N, Munoz-Ortega M, Sanchez-Aleman E, Avila-Blanco M Exp Ther Med. 2024; 28(4):392.

PMID: 39161617 PMC: 11332140. DOI: 10.3892/etm.2024.12681.

References
1.
Pastor-Anglada M, Mata-Ventosa A, Perez-Torras S . Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes ( and ). Int J Mol Sci. 2022; 23(15). PMC: 9369021. DOI: 10.3390/ijms23158770. View

2.
Karamouzis I, Sarafidis P, Karamouzis M, Iliadis S, Haidich A, Sioulis A . Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2007; 28(3):397-404. DOI: 10.1159/000112413. View

3.
Nguy L, Shubbar E, Jernas M, Nookaew I, Lundgren J, Olsson B . Adenine-induced chronic renal failure in rats decreases aortic relaxation rate and alters expression of proteins involved in vascular smooth muscle calcium handling. Acta Physiol (Oxf). 2016; 218(4):250-264. DOI: 10.1111/apha.12724. View

4.
Musgrove J, Wolf M . Regulation and Effects of FGF23 in Chronic Kidney Disease. Annu Rev Physiol. 2019; 82:365-390. DOI: 10.1146/annurev-physiol-021119-034650. View

5.
Chen Y, Mao C, Gu R, Zhao R, Li W, Ma Z . Nidogen-2 is a Novel Endogenous Ligand of LGR4 to Inhibit Vascular Calcification. Circ Res. 2022; 131(12):1037-1054. DOI: 10.1161/CIRCRESAHA.122.321614. View